Skip to content

Tuberculosis Treatment Compliance Under Smartphone-Based Video-Observed Therapy Versus Community-Based Directly Observed Therapy

Smartphone-video observed therapy versus directly observed therapy for enhancing treatment compliance among TB patients and their observers

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210624002
Enrollment
140
Registered
2021-06-24
Start date
2022-01-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active pulmonary Tuberculosis Tuberculosis Adherence

Interventions

A TB patient records his/herself taking medication with TH VOT app and uploads a video to the health service. Then the video will be reviewed by the observer. Finally, the auditor will review the acti

Sponsors

Thai Health Systems Research Institute
Lead Sponsor
National Institutes of Health
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: A cluster was considered eligible for the study based on an observer. An observer will be recruited to our study if he/she has a responsibility to observe at least one patient that meet all of the following criteria: 1. new case of active pulmonary TB with a positive acid-fast bacillus in sputum smear. 2. age more than 18 years old 3. able to use LINE application 4. live in Songkhla province

Exclusion criteria

Exclusion criteria: There is no exclusion criteria for a cluster, however the TB patient in the cluster will be excluded if he/she meet at least one of the following criteria: 1. has a condition that must be referred to the specialist 2. antibiotic sensitivity test (GeneXpert) shows rifampicin resistance 3. status is not compatible to continue treatment 4. alcohol dependent 5. migrant labour

Design outcomes

Primary

MeasureTime frame
Accountability At 2 months after starting intervention Percentage of patient timely observed ingestion of anti-TB drugs.

Secondary

MeasureTime frame
Smear conversion At 2 months after starting intervention Whether sputum turn from Acid-Fast Bacilli Smear positive at the begining to negative at the end of intensive phase,Adverse events reported. At 2 months after starting intervention Number of adverse events documented.

Countries

Thailand

Contacts

Public ContactVirasakdi Chongsuvivatwong

Prince of Songkla University

cvirasak@medicine.psu.ac.th66897350098

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026